Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients

2017-06-22

Blood , Volume 129 - Issue 25 p. 3389- 3391

Additional Metadata
Persistent URL	doi.org/10.1182/blood-2016-11-751719, hdl.handle.net/1765/108517
Journal	Blood
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Porcelijn, L., Huiskes, E. (Elly), Schipperus, M., van der Holt, B., de Haas, M., & Zwaginga, J. (2017). Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients. Blood, 129(25), 3389–3391. doi:10.1182/blood-2016-11-751719

Publication